Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease

Cited by (359)

Items 101–200 of 359

1. Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline
   Guoyu Lan, Yue Qin Cai, Anqi Li, Zhen Liu, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Annals of Neurology
2. CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease
   Masanori Kurihara, Hiroki Komatsu, Renpei Sengoku, Mari Shibukawa, Satoru Morimoto, Tomoyasu Matsubara, Akira Arakawa, Makoto Orita, Kenji Ishibashi, Akihiko Mitsutake et al. · 2022 · Neurology
3. Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes
   Antoine Leuzy, Niklas Mattsson, Nicholas C. Cullen, Erik Stomrud, Sebastian Palmqvist, Renaud La Joie, Leonardo Iaccarino, Henrik Zetterberg, Gil Dan Rabinovici, Kaj Blennow et al. · 2023 · Alzheimer s & Dementia
4. Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’s Disease
   John A. Hey, Susan R. Abushakra, Kaj Blennow, Eric M. Reiman, Jakub Hort, Niels D. Prins, Kateřina Sheardová, Patrick J. Kesslak, Larry Zaiqian Shen, Xinyi Zhu et al. · 2024 · Drugs
5. Tau positron emission tomography in preclinical Alzheimer’s disease
   Philip S. Insel, Christina B. Young, Paul S. S Aisen, Keith A. Johnson, Reisa Anne Sperling, Elizabeth C. Mormino, Michael Donohue · 2022 · Brain
6. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
   Yue Qin Cai, Jing Du, Anqi Li, Yalin Zhu, Linsen Xu, Kun Sun, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Alzheimer s Research & Therapy
7. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks
   Marta Milà‐Alomà, Duygu Tosun, Suzanne E. Schindler, Isabella Hausle, Kellen K. Petersen, Yan Li, Jeffrey L. Dage, Lei Du‐Cuny, Ziad S. Saad, Benjamin A. Saef et al. · 2025 · Annals of Neurology
8. Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis
   Yu Hirota, Yasufumi Sakakibara, Kyoko Ibaraki, Kimi Takei, Koichi Iijima, Michiko Sekiya · 2022 · Brain Communications
9. Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest
   Nicholas James Ashton, Marion Moseby Knappe, Andréa Lessa Benedet, Lana Grötschel, Juan Lantero‐Rodriguez, Thomas K. Karikari, Christian Hassager, Matt P. Wise, Pascal Stammet, Jesper Kjærgaard et al. · 2023 · JAMA Neurology
10. Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PET
    Petrice M. Cogswell, Emily S. Lundt, Terry M. Therneau, Heather J. Wiste, Jonathan Graff‐Radford, Alicia Algeciras‐Schimnich, Val J. Lowe, Michelle M. Mielke, Christopher G. Schwarz, Matthew L. Senjem et al. · 2023 · Alzheimer s & Dementia
11. Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum
    Jaime Fernández Arias, Wagner Scheeren Brum, Gemma Salvadó, Joseph Therriault, Stijn Servaes, Yi‐Ting Wang, Étienne Aumont, Nesrine Rahmouni, Arthur C. Macedo, Kely Monica Quispialaya et al. · 2025 · Brain
12. Plasma tau biomarkers for biological staging of Alzheimer’s disease
    Laia Montoliu‐Gaya, Gemma Salvadó, Joseph Therriault, Johanna Nilsson, Shorena Janelidze, Sophia Weiner, Nicholas James Ashton, Andréa Lessa Benedet, Nesrine Rahmouni, Juan Lantero‐Rodriguez et al. · 2025 · Nature Aging
13. Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease
    Yen Ying Lim, Paul T. Maruff, Nicolas R. Barthélemy, Alison Goate, Jason J. Hassenstab, Chihiro Sato, Anne M. Fagan, Tammie L.S. Benzinger, Chengjie Xiong, Carlos Cruchaga et al. · 2022 · JAMA Neurology
14. Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
    J. P. Ferrari-Souza, G. Povala, N. Rahmouni, B. Bellaver, P. Ferreira, M. D. de Bastiani, D. Leffa, F. Lussier, C. Aguzzoli, W. Brum et al. · 2025 · Nature Neuroscience
15. Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease
    Huanhuan Liu, Dandan Zhang, Huawei Lin, Qi Zhang, Ling Zheng, Yuxin Zheng, Xiaolong Yin, Zuanfang Li, Shengxiang Liang, Saie Huang · 2021 · Frontiers in Aging Neuroscience
16. P-tau217 in Alzheimer’s disease
    Julia Telser, Lorenz Risch, Christoph H. Saely, Kirsten Grossmann, Philipp Werner · 2022 · Clinica Chimica Acta
17. Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
    Smith, Ruben, Hägerström, Douglas, Pawlik, Daria, Klein, Gregory, Jögi, Jonas, Ohlsson, Tomas, Stomrud, Erik, Hansson, Oskar · 2023 · JAMA Neurology
18. Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease
    Clara Vila‐Castelar, Yinghua Chen, Stephanie Langella, Francisco Javier Lopera, Henrik Zetterberg, Oskar Hansson, Jeffrey L. Dage, Shorena Janelidzde, Yi‐Chang Su, Kewei Chen et al. · 2023 · Alzheimer s & Dementia
19. APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
    Aylin Dincer, Charles D. Chen, Nicole Sarah McKay, Lauren N. Koenig, Austin A. McCullough, Shaney E. Flores, Sarah Keefe, Stephanie A. Schultz, Rebecca L. Feldman, Nelly Joseph‐Mathurin et al. · 2022 · Science Translational Medicine
20. Spatial and temporal patterns of cortical mean diffusivity in Alzheimer's disease and suspected non‐Alzheimer's disease pathophysiology
    Pan Sun, Zhengbo He, Anqi Li, Jie Yang, Yalin Zhu, Yue Qin Cai, Ting Ma, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
21. Neuroimaging of mouse models of Alzheimer’s disease
    Jullienne, Amandine, Trinh, Michelle V., Obenaus, Andre · 2022 · Biomedicines
22. Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults
    Emer R. McGrath, Alexa Beiser, Adrienne O’Donnell, Qiong Yang, Saptaparni Ghosh, Mitzi M. Gonzales, Jayandra Jung Himali, Claudia Liliana Satizábal, Keith A. Johnson, Russell P. Tracy et al. · 2022 · Journal of Alzheimer s Disease
23. Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
    Steffi De Meyer, Jeroen Vanbrabant, Jolien M. Schaeverbeke, Mariska Reinartz, Emma Susanne Luckett, Patrick J. Dupont, Koen Van Laere, Erik Stoops, Eugeen Vanmechelen, Koen Poesen et al. · 2022 · Annals of Clinical and Translational Neurology
24. Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline
    Guoyu Lan, Anqi Li, Zhen Liu, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Alzheimer s & Dementia
25. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases
    Masanori Kurihara, Tomoyasu Matsubara, Satoru Morimoto, Akira Arakawa, Kensuke Ohse, Kazutomi Kanemaru, Atsushi Iwata, Shigeo Murayama, Yuko Saito · 2024 · Acta Neuropathologica Communications
26. The Blood-Brain Barrier in Alzheimer’s Disease
    Steffen E. Storck, Anika M. S. Hartz, Claus U. Pietrzik · 2020 · Handbook of experimental pharmacology
27. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β
    Claudia Cicognola, Gemma Salvadó, Ruben A Smith, Sebastian Palmqvist, Erik Stomrud, Tobey J. Betthauser, Sterling C. Johnson, Shorena Janelidze, Niklas Mattsson, Oskar Hansson et al. · 2025 · Brain
28. Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
    Emelie Andersson, Nils Lindblom, Shorena Janelidze, Gemma Salvadó, Eleni Gkanatsiou, Linda Söderberg, Christer Möller, Lars Lannfelt, Junyue Ge, Jörg Hanrieder et al. · 2025 · Nature Aging
29. Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
    Chiara Giangrande, Vincent Delatour, Ulf Andréasson, Kaj Blennow, Johan Gobom, Henrik Zetterberg · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
30. Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
    Jiaying Lu, Xiaoxi Ma, Huiwei Zhang, Zhenxu Xiao, Ming Li, Jie Wu, Zizhao Ju, Li Chen, Li Zheng, Jingjie Ge et al. · 2023 · Translational Neurodegeneration
31. A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles
    Samantha C. Burnham, Leonardo Iaccarino, Michael J. Pontecorvo, Adam Fleisher, Ming‐Chi Lu, Emily C. Collins, Michael D. Devous · 2023 · Brain Communications
32. Nanoscale imaging of pT217‐tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early‐stage neurodegeneration
    Dibyadeep Datta, Isabella Perone, Denethi Wijegunawardana, Feng Liang, Yury M. Morozov, Jon I. Arellano, Alvaro Duque, Zhongcong Xie, Christopher H. van Dyck, Mary Kate P. Joyce et al. · 2024 · Alzheimer s & Dementia
33. Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
    Roman Sattarov, Megan Havers, Camilla Orbjörn, Erik Stomrud, Shorena Janelidze, Thomas Laurell, Niklas Mattsson · 2024 · Scientific Reports
34. Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
    Kadamangudi, Shrinath, Marcatti, Michela, Zhang, Wen-Ru, Fracassi, Anna, Kayed, Rakez, Limon, Agenor, Taglialatela, Giulio · 2024 · Acta Neuropathologica
35. Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer’s disease
    Swetha Ravichandran, Peter Jeffrey Snyder, Jessica Alber, Charles Murchison, Lauren E. Chaby, Andreas Jeromin, Edmund Arthur · 2025 · Alzheimer s Research & Therapy
36. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
    Karine Provost, Leonardo Iaccarino, David N. Soleimani‐Meigooni, Suzanne L. Baker, Lauren Edwards, Udo Eichenlaub, Oskar Hansson, William J. Jagust, Mustafa Janabi, Renaud La Joie et al. · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
37. Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives
    Bin-Lu Sun, Yang Chen, Dong-Yu Fan, Chi Zhu, Fan Zeng, Yan-Jiang Wang · 2020 · Science China Life Sciences
38. Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
    Daniel D. Lee, Virginia M.‐Y. Lee, Seong Kwon Hur · 2022 · Frontiers in Neuroscience
39. Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer’s Disease Continuum
    Yuto Uchida, Kengo Onda, Zhipeng Hou, Juan Carlos Troncoso, Susumu Mori, Kenichi Oishi · 2023 · Journal of Alzheimer s Disease
40. Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
    Tengfei Guo, Susan M. Landau, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Alzheimer s Research & Therapy
41. Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease
    Khazar Ahmadi, Joana B. Pereira, David Berron, Jacob W. Vogel, Silvia Ingala, Olof T. Strandberg, Shorena Janelidze, Frederik Barkhof, Josef Pfeuffer, Linda Knutsson et al. · 2022 · Journal of Cerebral Blood Flow & Metabolism
42. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
    Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, Minerva M. Carrasquillo, Xue Wang, Chia‐Chen Liu, Yu Yamazaki, Thuy Nguyen, Kimberly G. Malphrus, Michael G. Heckman et al. · 2023 · Molecular Neurodegeneration
43. MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
    Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory Scott Day, Albert A. Davis, Albert H. Kim, Gregory Joseph Zipfel, Randall John Bateman, Audrey Gabelle et al. · 2021 · Annals of Clinical and Translational Neurology
44. Lactobacillaceae improve cognitive dysfunction via regulating gut microbiota and suppressing Aβ deposits and neuroinflammation in APP/PS1 mice
    Yusong Wu, Xiaohui Niu, Peifan Li, Tong Tong, Qinger Wang, Michael Zhang, Yongli Li, Jia Liu, Zuming Li · 2023 · Archives of Microbiology
45. The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
    Gilda E. Ennis, Tobey J. Betthauser, Rebecca L. Koscik, Nathaniel A. Chin, Bradley T. Christian, Sanjay Asthana, Sterling C. Johnson, Barbara B. Bendlin · 2023 · Alzheimer s Research & Therapy
46. Proteomic indicators of health predict Alzheimer’s disease biomarker levels and dementia risk
    H. E. Dark, Clare Paterson, Gulzar N. Daya, Zhong-Sheng Peng, Michael R. Duggan, Murat Bilgel, Yang An, A. Moghekar, C. Davatzikos, S. Resnick et al. · 2023 · Annals of Neurology
47. Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies
    Roxane Dilcher, Stephan Wall, Mattes Groß, Sabrina Katzdobler, Olivia Wagemann, Carla Palleis, Endy Weidinger, Urban M. Fietzek, Alexander Bernhardt, Carolin Kurz et al. · 2024 · Alzheimer s & Dementia
48. Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease
    Gabriele Vilkaite, Jacob W. Vogel, Niklas Mattsson · 2024 · Cell Reports Medicine
49. Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
    Zhen Guo, Chen Tian, Yang Shi, Xueru Song, Wei Yin, Qing‐Qing Tao, Jie Liu, Guo-Ping Peng, Zhi‐Ying Wu, Yan‐Jiang Wang et al. · 2024 · Acta Neuropathologica Communications
50. Protein modification in neurodegenerative diseases
    Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, Nasrin Seddigh, Abdollah Allahverdi · 2024 · MedComm
51. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study
    Emma E. Wolters, Marleen H.C.T. Van Beek, Rik Ossenkoppele, Sandeep S.V. Golla, Sander C.J. Verfaillie, Emma M. Coomans, Tessa Timmers, Denise Visser, Hayel Tuncel, Frederik Barkhof et al. · 2020 · NeuroImage Clinical
52. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns
    Ondřej Lerch, Daniel Ferreira, Erik Stomrud, Danielle van Westen, Pontus Tideman, Sebastian Palmqvist, Niklas Mattsson, Jakub Hort, Oskar Hansson, Eric Westman · 2024 · Alzheimer s Research & Therapy
53. Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
    Branislav Kováčech, Nicholas C. Cullen, Petr Novák, Jozef Hanes, Eva Kontseková, Stanislav Katina, Vojtech Parrák, Michal Fresser, Jeroen Vanbrabant, Howard Feldman et al. · 2024 · Alzheimer s Research & Therapy
54. The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells
    Adolfo López-Ornelas, A. Jiménez, G. Pérez-Sánchez, C. Rodríguez-Pérez, Alejandro Corzo-Cruz, Iván Velasco, Enrique Estudillo · 2022 · International Journal of Molecular Sciences
55. Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion
    Nagaendran Kandiah, Seong Hye Choi, Chaur‐Jong Hu, Kenji Ishii, Kensaku Kasuga, Vincent Mok · 2022 · Journal of Alzheimer s Disease Reports
56. Distinct spatiotemporal subtypes of amyloid deposition are associated with diverging disease profiles in cognitively normal and mild cognitive impairment individuals
    Yuqing Sun, Yuxin Zhao, Ke Hu, Meng Wang, Yong Liu, Bing Liu, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Translational Psychiatry
57. The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
    Martin Tolar, John A. Hey, Aidan Power, Susan R. Abushakra · 2024 · International Journal of Molecular Sciences
58. Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease
    Kyu Hwan Shim, Danyeong Kim, Min Ju Kang, Jung‐Min Pyun, Young Ho Park, Young Chul Youn, Kyung Won Park, Kyoungho Suk, Ho‐Won Lee, Bárbara Fernandes Gomes et al. · 2024 · Alzheimer s & Dementia
59. Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring
    Melissa E. Petersen, Lisi Flores Aguilar, Elizabeth Head, Laia Montoliu‐Gaya, André Strydom, Sarah E. Pape, Juan Fortea, Nicholas James Ashton, Chinedu Theresa Udeh‐Momoh, Sid E. O’Bryant et al. · 2024 · Alzheimer s & Dementia
60. Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?
    Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling · 2020 · Expert Opinion on Drug Discovery
61. New progress on the role and mechanism of tau protein in Alzheimer's disease and depression
    Yamei Wang, Jing Zhou, Qingqing Zhou, Hua Wang · 2025 · Frontiers in Neurology
62. Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
    Seyed Hani Hojjati, Tracy Butler, Gloria Chia-Yi Chiang, Christian Georg Habeck, Arindam RoyChoudhury, Farnia Feiz, Jacob Shteingart, Siddharth Nayak, Sindy Ozoria, Antonio Fernández Guerrero et al. · 2023 · NeuroImage Clinical
63. Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
    Sheng‐Min Wang, Dong Woo Kang, Yoo Hyun Um, Sunghwan Kim, Chang Uk Lee, Philip Scheltens, Hyun Kook Lim · 2024 · Alzheimer s Research & Therapy
64. Peripheral HMGB1 is linked to O3 pathology of disease‐associated astrocytes and amyloid
    Chandrama Ahmed, Hendrik J. Greve, Carla Garza-Lombó, Jamie A. Malley, James Johnson, Adrian L. Oblak, Michelle L. Block · 2024 · Alzheimer s & Dementia
65. The emerging role of exercise in Alzheimer’s disease: Focus on mitochondrial function
    Lili Feng, Bowen Li, Su Sean Yong, Wen Xu, Zhenjun Tian · 2024 · Ageing Research Reviews
66. Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer’s disease and other neurodegenerative dementias in a large Chinese cohort
    Bin Jiao, Ziyu Ouyang, Yiliang Liu, Cong Zhang, Tianyan Xu, Qijie Yang, Sizhe Zhang, Yuan Zhu, Meidan Wan, Xuewen Xiao et al. · 2025 · Alzheimer s Research & Therapy
67. Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer’s disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer’s dementia
    Fang Yu, SeungYong Han, Dereck L. Salisbury, Jeremy J. Pruzin, Yonas E. Geda, Richard J. Caselli, Danni Li · 2022 · Pilot and Feasibility Studies
68. Lowering levels of reelin in entorhinal cortex layer II-neurons results in lowered levels of intracellular amyloid-β
    Asgeir Kobro‐Flatmoen, Claudia Battistin, Rajeevkumar Raveendran Nair, Christiana Bjorkli, Belma Skender, Clifford G. Kentros, Gunnar K. Gouras, Menno P. Witter · 2023 · Brain Communications
69. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
    Guido Maria Giuffrè, Davide Quaranta, Emanuele Maria Costantini, Salvatore Citro, Noemi Martellacci, Grazia De Ninno, Maria Gabriella Vita, Valeria Guglielmi, Paolo Maria Rossini, Paolo Calabresi et al. · 2023 · Neurobiology of Disease
70. Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer’s disease model mice
    Katherine R. Sadleir, Karen Gómez, Abigail E. Edwards, Armana J. Patel, Makenna L. Ley, Ammaarah W. Khatri, Joanna Guo, Shreya Mahesh, Elyse A. Watkins, Jelena Popović et al. · 2025 · Acta Neuropathologica
71. Fully Integrated Wearable Biosensor for Multiple In Situ Phosphorylated Tau Protein Detection
    Xin Sun, Geng Zhong, Yu Zeng, Tailin Xu, Yibiao Liu · 2025 · Analytical Chemistry
72. The 2024 NIA-AA biological definition of Alzheimer’s disease: linking biomarkers to clinical practice
    Goh Kobayashi, Kosei Hirata, Maiko Ono, Kensaku Kasuga, Yuhei Takado · 2026 · Frontiers in Dementia
73. A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline
    Yuqing Sun, Meng Wang, Yuxin Zhao, Ke Hu, Yong Liu, Bing Liu, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Journal of Alzheimer s Disease
74. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid
    Geoffroy Pierre Gagliardi, Elena Rodriguez‐Vieitez, Víctor Montal, Jorge Sepulcre, Ibai Palacio Diez, Cristina Lois, Bernard Jimmy Hanseeuw, Aaron P. Schultz, Michael J Properzi, Kathryn V. Papp et al. · 2023 · Communications Medicine
75. β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
    Atul Kumar, Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Niklas Mattsson, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Neurology
76. Towards early diagnosis of Alzheimer’s disease: advances in immune-related blood biomarkers and computational approaches
    Sophia Krix, Ella Wilczynski, Neus Falgàs, Raquel Sánchez‐Valle, Eti Yoles, Uri Nevo, Kuti Baruch, Holger Fröhlich · 2024 · Frontiers in Immunology
77. Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease
    Toomas Erik Anijärv, Rik Ossenkoppele, Ruben A Smith, Alexa Pichet Binette, Lyduine Eisa Collij, Hamid Behjat, Jonathan Ö. Rittmo, Linda Karlsson, Khazar Ahmadi, Olof T. Strandberg et al. · 2025 · Nature Communications
78. ELISA Evaluation of Tau Accumulation in the Brains of Patients with Alzheimer Disease
    Mitsuru Shinohara, Junko Hirokawa, Akemi Shimodaira, Yoshitaka Tashiro, Kaoru Suzuki, Ghupurjan Gheni, Akio Fukumori, Tomoyasu Matsubara, Maho Morishima, Yuko Saito et al. · 2021 · Journal of Neuropathology & Experimental Neurology
79. The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
    Hyung‐Ji Kim, Jungsu S. Oh, Jae‐Sung Lim, Sunju Lee, Sungyang Jo, E-Nae Chung, Woo Hyun Shim, Minyoung Oh, Jae Seung Kim, Jee Hoon Roh et al. · 2022 · Alzheimer s Research & Therapy
80. Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
    Taeko Kimura, Haruaki Sato, Maria Kano, Lisa Tatsumi, Taisuke Tomita · 2023 · FEBS Open Bio
81. Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
    Alexandra Wicker, Jahnavi Shriram, Boris Decourt, Marwan Noel Sabbagh · 2024 · Neurology and Therapy
82. Head‐to‐Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study
    David N. Soleimani‐Meigooni, Ruben A Smith, Karine Provost, Orit H. Lesman‐Segev, Isabel Elaine Allen, Miranda K. Chen, Hanna Cho, Lauren Edwards, Shorena Janelidze, Renaud La Joie et al. · 2024 · Annals of Neurology
83. Biofluid-based staging of Alzheimer’s disease
    Juan Lantero‐Rodriguez, Laia Montoliu‐Gaya, Nicholas James Ashton, Ilaria Pola, Joseph Therriault, Nesrine Rahmouni, Wagner Scheeren Brum, Stijn Servaes, Jenna Stevenson, Guglielmo Di Molfetta et al. · 2025 · Acta Neuropathologica
84. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline
    Guoyu Lan, Jing Du, Xuhui Chen, Qingyong Wang, Ying Han, Tengfei Guo · 2023 · Neurobiology of Aging
85. β-Amyloid discordance of cerebrospinal fluid and positron emission tomography imaging shows distinct spatial tau patterns
    Chenyang Jiang, Qingyong Wang, Siwei Xie, Zhicheng Chen, Liping Fu, Qiyu Peng, Ying Liang, Hongbo Guo, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
86. Genetically identical twin-pair difference models support the amyloid cascade hypothesis
    Emma M. Coomans, Jori Tomassen, Rik Ossenkoppele, Betty Marije Tijms, Luigi Lorenzini, Mara ten Kate, Lyduine Eisa Collij, Fiona Heeman, Roos M. Rikken, Sophie M. van der Landen et al. · 2023 · Brain
87. Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer’s Disease
    Asgeir Kobro‐Flatmoen, Thea Meier Hormann, Gunnar K. Gouras · 2023 · Journal of Alzheimer s Disease
88. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease
    Peter R Millar, Brian Andrew Gordon, Julie K. Wisch, Stephanie A. Schultz, Tammie L.S. Benzinger, Carlos Cruchaga, Jason J. Hassenstab, Laura Ibáñez, Celeste M M. Karch, Jorge J. Llibre‐Guerra et al. · 2023 · Molecular Neurodegeneration
89. Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s
    Gemma Salvadó, Kanta Horie, Nicolas R. Barthélemy, Jacob W. Vogel, Alexa Pichet Binette, Charles D. Chen, Andrew J. Aschenbrenner, Brian Andrew Gordon, Tammie L.S. Benzinger, David M. Holtzman et al. · 2023 · Alzheimer s & Dementia
90. A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease
    Malamati Kourti, Athanasios Metaxas · 2024 · Neurobiology of Disease
91. A multi-cohort study of the hippocampal radiomics model and its associated biological changes in Alzheimer’s Disease
    Huwei Xia, Xiao-Qian Luan, Zhengkai Bao, Qin-Xin Zhu, Cai-Yun Wen, Mei-Hao Wang, Wei-Hong Song · 2024 · Translational Psychiatry
92. Recent advances in pre-clinical diagnosis of Alzheimer’s disease
    John Zhou, Marc Benoit, Md Golam Sharoar · 2021 · Metabolic Brain Disease
93. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
    Annie G. Bryant, Mary Kate Manhard, David H. Salat, Bruce Robert Rosen, Bradley T. Hyman, Keith A. Johnson, Susie Y. Huang, Rachel E. Bennett, Yi‐Fen Yen · 2021 · Current Alzheimer Research
94. Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort
    Menayit Tamrat Dresse, Pâmela C.L. Ferreira, Akshay Prasadan, Jihui L. Diaz, Xuemei Zeng, Bruna Bellaver, Guilherme Povala, Victor L. Villemagne, M. Ilyas Kamboh, Ann D. Cohen et al. · 2025 · Alzheimer s Research & Therapy
95. Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data
    Moeko Noguchi‐Shinohara, Takahiro Yoshinobu, Taro Ozaki et al. · 2025 · Alzheimer s Research & Therapy
96. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging
    Parag A Parekh, Qingshan Mu, Andrew Badachhape, Rohan C. Bhavane, Mayank Srivastava, Laxman Devkota, Xianwei Sun, Prajwal Bhandari, Jason L. Eriksen, Eric A. Tanifum et al. · 2022 · Theranostics
97. Phosphorylated tau in Alzheimer’s disease
    Julia Telser, Kirsten Grossmann, Niklas Wohlwend, Lorenz Risch, Christoph H. Saely, Philipp Werner · 2023 · Advances in clinical chemistry
98. Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers
    Joachim Strobel, Elham Yousefzadeh‐Nowshahr, Katharina Deininger, Karl Peter Bohn, Christine A. F. Von Arnim, Markus Otto, Christoph Solbach, Sarah Anderl‐Straub, Dörte Polivka, Patrick Fissler et al. · 2024 · Biomedicines
99. Plasma N‐terminal tau fragment is an amyloid‐dependent biomarker in Alzheimer's disease
    Guoyu Lan, Laihong Zhang, Anqi Li, Wenqing Ran, Jieqin Lv, Fernando González‐Ortiz, Yue Qin Cai, Pan Sun, Lin Liu, Jie Yang et al. · 2025 · Alzheimer s & Dementia
100. Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimerʼs disease in a Chinese cohort
     Limin Li, Ping Che, Dequan Liu, Yu Wang, Jia Li, Dian He, Tao Liu, Nan Zhang · 2025 · The Journal of Prevention of Alzheimer s Disease